Omega-3s and asthma
This article was originally published in The Tan Sheet
"Fish oil supplementation may represent a potentially beneficial nonpharmacologic intervention for asthmatic subjects" with exercise-induced asthma, a small study in the January issue of Chest finds. The randomized, double-blind crossover study evaluated 16 asthma patients with documented exercise-induced asthma. Patients received either 3.2 g EPA and 2 g DHA or placebo daily for three weeks, then served as their own controls after a two-week washout period. At initial screening and at the end of each three-week treatment, pulmonary function was assessed before and during exercise while running on a treadmill. "Bronchodilator use was significantly reduced during the last two weeks of the fish oil diet compared to the normal diet and placebo diet," Timothy Mickleborough, PhD, Indiana University, et al., find...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”